BE726681A - - Google Patents

Info

Publication number
BE726681A
BE726681A BE726681DA BE726681A BE 726681 A BE726681 A BE 726681A BE 726681D A BE726681D A BE 726681DA BE 726681 A BE726681 A BE 726681A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE726681A publication Critical patent/BE726681A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
BE726681D 1968-01-10 1969-01-09 BE726681A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0536/68A GB1202607A (en) 1968-01-10 1968-01-10 Improvements in or relating to stable glucagon solutions and their preparation

Publications (1)

Publication Number Publication Date
BE726681A true BE726681A (en:Method) 1969-07-09

Family

ID=9723689

Family Applications (1)

Application Number Title Priority Date Filing Date
BE726681D BE726681A (en:Method) 1968-01-10 1969-01-09

Country Status (7)

Country Link
AT (1) AT283600B (en:Method)
BE (1) BE726681A (en:Method)
DE (1) DE1900367A1 (en:Method)
FR (1) FR2000114A1 (en:Method)
GB (1) GB1202607A (en:Method)
IT (1) IT974528B (en:Method)
NL (1) NL6900460A (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6384016B1 (en) * 1998-03-13 2002-05-07 Novo Nordisk A/S Stabilized aqueous peptide solutions
US7235627B2 (en) 1996-08-30 2007-06-26 Novo Nordisk A/S Derivatives of GLP-1 analogs
WO1999047160A1 (en) * 1998-03-13 1999-09-23 Novo Nordisk A/S Stabilized aqueous peptide solutions
US9610329B2 (en) 2009-10-22 2017-04-04 Albireo Pharma, Inc. Stabilized glucagon solutions
DK2490708T3 (da) 2009-10-22 2013-04-15 Biodel Inc Stabiliserede glucagon-opløsninger
JP5894174B2 (ja) * 2010-11-03 2016-03-23 アレコー リミテッド グルカゴンを含む新規組成物
BR112014016889A8 (pt) 2012-01-09 2017-07-04 Adocia composição sob a forma de uma solução aquosa injetável, sujo ph está compreendido entre 6,0 e 8,0 e, formulação de dose unitária com ph compreendido entre 7 e 7,8
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
FR3061660B1 (fr) * 2017-01-10 2019-05-31 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
EP3463295B1 (fr) * 2016-06-07 2020-08-05 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacidegreffe en bout de chaine
FR3052071B1 (fr) * 2016-06-07 2018-09-07 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
MA51017A (fr) 2017-12-07 2021-03-17 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
KR20240171195A (ko) 2017-12-07 2024-12-06 아도시아 인간 글루카곤 및 코-폴리아미노산을 포함하는 주사용 수용액 형태의 조성물
WO2019110838A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3083087A1 (fr) 2018-06-29 2020-01-03 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
US10987426B2 (en) * 2017-12-07 2021-04-27 Adocia Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
FR3074683B1 (fr) * 2017-12-07 2020-01-10 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3067247A1 (fr) 2018-06-07 2018-12-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2643967A (en) * 1946-08-31 1953-06-30 Wallerstein Co Inc Concentrate of tyrothricin and its therapeutically active components
NL94376C (nl) * 1958-04-28 1960-05-16 Nv Organon Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking

Also Published As

Publication number Publication date
NL6900460A (en:Method) 1969-07-14
IT974528B (it) 1974-07-10
FR2000114A1 (fr) 1969-08-29
AT283600B (de) 1970-08-10
GB1202607A (en) 1970-08-19
DE1900367A1 (de) 1969-09-04

Similar Documents

Publication Publication Date Title
AU1946070A (en:Method)
AU428130B2 (en:Method)
AU2374870A (en:Method)
AU5184069A (en:Method)
AU6168869A (en:Method)
AU6171569A (en:Method)
AU416157B2 (en:Method)
AU429879B2 (en:Method)
AU2581067A (en:Method)
AU4811568A (en:Method)
AU421558B1 (en:Method)
AU3789668A (en:Method)
AU3224368A (en:Method)
AU4744468A (en:Method)
AU2580267A (en:Method)
AU4224469A (en:Method)
BE708888A (en:Method)
AU463027A (en:Method)
AU4503667A (en:Method)
AU479393A (en:Method)
AU479894A (en:Method)
AU4464266A (en:Method)
AU4270368A (en:Method)
AU3083868A (en:Method)
AU5758767A (en:Method)